Zhejiang Shengda Bio-Pharm Co., Ltd. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced sales was CNY 196.538 million compared to CNY 121.191 million a year ago. Operating income was CNY 73.636 million compared to CNY 17.178 million a year ago. Net income was CNY 62.427 million compared to CNY 14.112 million a year ago. Basic earnings per share from continuing operations was CNY 0.53 compared to CNY 0.13 a year ago. Diluted earnings per share from continuing operations was CNY 0.49 compared to CNY 0.13 a year ago.